![](/img/cover-not-exists.png)
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Antoaneta Tomova, Rupert Bartsch, Thomas Brodowicz, Valentina Tzekova, Constanta Timcheva, Christoph Wiltschke, Dany Abi Gerges, Jan Pawlega, Stanislav Spanik, Moshe Inbar, Christoph C. ZielinskiVolume:
119
Language:
english
Pages:
8
DOI:
10.1007/s10549-009-0553-4
Date:
January, 2010
File:
PDF, 277 KB
english, 2010